NeuroSense Announces Third Quarter 2022 Financial Results and Provides Business Update
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
Stay updated with breaking news from Scientific Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
/PRNewswire/ -- The International Market Access Society (IMAS) announced the appointment of 12 members to its Scientific Program Committee. Members of this...
November 21, 2022, Cypress, California (PRWEB) November 23, 2022 -- AAGL Global Congress will welcome physicians from all over the world online and live at
Ten months after transplanting the first genetically-modified pig heart into a human patient, University of Maryland School of Medicine researchers continue to report on new findings from the landmark transplant.
Umsom researchers report on new findings from heart monitoring systems at American Heart Association meetingÂ